Adeno-Associated Virus-Like Particle (AAVLP)-Based Neoantigen Vaccine Significantly Enhances Anti-Tumor Efficacy

Cancer vaccination addressing neo-antigens based on the mutanome of an established tumor is the most personalized immunotherapeutic approach so far. First clinical results in melanoma and pancreatic cancer indicate the induction of a